December 22, 2014 — Advanced Vascular Dynamics (AVD) announced U.S. Food and Drug Administration (FDA) clearance and CE mark for the RadAR vascular compression devices for post-procedure hemostasis of tibiopedal access sites, including the dorsalis pedis and posterior tibial arteries. The RadAR devices were previously cleared for use for post-catheterization radial artery hemostasis.
The device feature a unique compression adjustment mechanism to easily enable patent hemostasis, expanding their utilization in vascular surgery and interventional radiology labs as use of the retrograde tibiopedal access technique expands.
A new approach to treating peripheral arterial disease and critical limb ischemia, retrograde tibiopedal access is particularly useful in treating chronic total occlusions and can be an effective alternative to antegrade recanalization.
For further information: www.compressar.com
November 14, 2025 
